The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(4-(4-amino-3-chlorobenzylsulfonyl)piperazin-1-yl)-2-(3,5-difluorophenyl)-4-((1-methylcyclopropyl)methoxy)pyridazin-3(2H)-one ID: ALA2059494
PubChem CID: 25073658
Max Phase: Preclinical
Molecular Formula: C26H28ClF2N5O4S
Molecular Weight: 580.06
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC1(COc2c(N3CCN(S(=O)(=O)Cc4ccc(N)c(Cl)c4)CC3)cnn(-c3cc(F)cc(F)c3)c2=O)CC1
Standard InChI: InChI=1S/C26H28ClF2N5O4S/c1-26(4-5-26)16-38-24-23(14-31-34(25(24)35)20-12-18(28)11-19(29)13-20)32-6-8-33(9-7-32)39(36,37)15-17-2-3-22(30)21(27)10-17/h2-3,10-14H,4-9,15-16,30H2,1H3
Standard InChI Key: XZTQXLZIVTWCHQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 43 0 0 0 0 0 0 0 0999 V2000
0.7164 -13.2394 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1327 -13.9557 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.5449 -13.2369 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.2988 -16.8418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3000 -17.6687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5856 -18.0814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8694 -17.6683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8723 -16.8381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5874 -16.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1561 -16.4215 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4405 -16.8333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7301 -16.4219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7290 -15.5969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4444 -15.1851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1612 -15.5983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8764 -15.1879 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0119 -15.1880 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2980 -15.6025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4140 -15.1937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4183 -14.3688 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2957 -13.9543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0139 -14.3647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8465 -14.3742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5622 -13.9646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2733 -14.3831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9885 -13.9742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9921 -13.1487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2745 -12.7339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5623 -13.1451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.0144 -16.4296 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-2.4447 -14.3605 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.1591 -13.9485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1594 -13.1239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7453 -12.4129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5699 -12.4132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8773 -13.5309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7072 -12.7382 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7008 -14.3895 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-4.5936 -18.9033 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
17 22 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
13 17 1 0
20 2 1 0
6 7 2 0
2 23 1 0
2 1 2 0
23 24 1 0
7 8 1 0
24 25 2 0
10 15 1 0
25 26 1 0
11 12 2 0
26 27 2 0
12 13 1 0
27 28 1 0
13 14 2 0
28 29 2 0
29 24 1 0
14 15 1 0
4 30 1 0
8 10 1 0
14 31 1 0
4 5 2 0
31 32 1 0
15 16 2 0
32 33 1 0
34 33 1 0
35 34 1 0
33 35 1 0
17 18 1 0
8 9 2 0
9 4 1 0
33 36 1 0
10 11 1 0
27 37 1 0
3 2 2 0
26 38 1 0
5 6 1 0
6 39 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 580.06Molecular Weight (Monoisotopic): 579.1519AlogP: 3.58#Rotatable Bonds: 8Polar Surface Area: 110.76Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 2.71CX LogP: 2.79CX LogD: 2.79Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.41Np Likeness Score: -1.26
References 1. Kuang R, Wu H, Ting PC, Aslanian RG, Cao J, Kim DW, Lee JF, Schwerdt J, Zhou G, Herr RJ, Zych AJ, Yang J, Lam SQ, Jenkins DM, Sakwa SA, Wainhaus S, Black TA, Cacciapuoti A, McNicholas PM, Xu Y, Walker SS.. (2012) The optimization of pyridazinone series of glucan synthase inhibitors., 22 (16): [PMID:22818082 ] [10.1016/j.bmcl.2012.06.091 ]